Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review - eClinicalMedicine
For Authors: Submit your work
Preprints are the future but peer review is still king' - Research Professional News
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression - The Lancet
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study - The Lancet Infectious Diseases
Robustness of evidence reported in preprints during peer review - The Lancet Global Health
The Lancet Oncology
The Lancet Digital Health
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet
First Look - SSRN | Elsevier
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials - The Lancet Microbe
Preprints with The Lancet: joining online research discussion platforms - The Lancet
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil - The Lancet
The Lancet Commission on lessons for the future from the COVID-19 pandemic - The Lancet
The Lancet on X: "NEW—Most reliable estimates to date suggest 1 in 8 COVID-19 patients develop #longCOVID symptoms. https://t.co/wechj5flvg https://t.co/pT8lBAWS4g" / X
The Lancet Regional Health – Americas
For Authors: Submit your work
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly - The Lancet
A new paradigm is needed to explain long COVID - The Lancet Respiratory Medicine
The Lancet Infectious Diseases, January 2024, Volume 24, Issue 1, Pages 1-106, e1-e69
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis - The Lancet
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases
Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility - The Lancet Global Health
Many scientists citing two scandalous COVID-19 papers ignore their retractions | Science | AAAS
How swamped preprint servers are blocking bad coronavirus research
Flawed preprint based on autopsies inadequate to demonstrate that COVID-19 vaccines caused 74% of those deaths - Health Feedback
